Join us! hVIVO presenting two posters and an oral presentation at the ISIRV Options X conference, Singapore, Asia, August 2019

July 25, 2019 11:39 am

ISIRV Options X Conference, August 28 – September 01, 2019, SUNTEC Singapore, Asia

hVIVO is pleased to announce that one oral presentation will be given and two posters presented at the ISIRV Options X 2019 conference. The conference is ISIRV’s (International Society for Influenza and other Respiratory Virus Diseases) flagship event and is the largest international conference dedicated to influenza prevention, control and treatment.

hVIVO will present one oral presentation and two scientific posters showcasing its extensive experience conducting influenza human challenge studies.

  • “Pre-existing NP specific T-cell response correlates with reduction of symptoms in a human Influenza challenge model”
    Dr Nicolas Noulin, Associate Director, Clinical Science, hVIVO, co-presented the oral presentation with Delphine Guyon-Gellin, Chief Business Development Officer, Osivax, Lyon, France.
    Saturday Aug 31, 14:00 – 15:30 (Session 8)
  • “Development and validation of algorithm’s prognostic for influenza contagiousness”
    Dr Nicolas Noulin, Associate Director, Clinical Science, hVIVO
    Wednesday Aug 28, 18:30 – 19:30 (Hall 404, Level 4)
  • “Human Viral Challenge Model With A/PERTH/16/2009: A systematic analysis from five clinical studies.”
    Dr Nicolas Noulin, Associate Director, Clinical Science, hVIVO
    Wednesday Aug 28, 18:30 – 19:30 (Hall 404, Level 4)

Representatives from hVIVO attending Options X are:

  • Dr Nicolas Noulin, Associate Director, Clinical Science
  • Jonathan Quinn, Director Business Development

If you would like to schedule a meeting with hVIVO at Options X, contact us here.

Comments are closed here.